CN121926911A - N,n-双-2-巯基乙基间苯二甲酰胺的新用途 - Google Patents

N,n-双-2-巯基乙基间苯二甲酰胺的新用途

Info

Publication number
CN121926911A
CN121926911A CN202511855908.5A CN202511855908A CN121926911A CN 121926911 A CN121926911 A CN 121926911A CN 202511855908 A CN202511855908 A CN 202511855908A CN 121926911 A CN121926911 A CN 121926911A
Authority
CN
China
Prior art keywords
paracetamol
pharmaceutically acceptable
nbmi
toxicity
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202511855908.5A
Other languages
English (en)
Chinese (zh)
Inventor
博伊德·尤金·哈利
雷格纳·阿克塞尔·西奥多·克林伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emeramed Ltd
Original Assignee
Ermes Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ermes Medical Co Ltd filed Critical Ermes Medical Co Ltd
Publication of CN121926911A publication Critical patent/CN121926911A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202511855908.5A 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途 Pending CN121926911A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1613535.2 2016-08-05
GB201613535 2016-08-05
PCT/GB2017/052306 WO2018025049A1 (en) 2016-08-05 2017-08-04 New use of n,n-bis-2-mercaptoethyl isophthalamide
CN201780046065.1A CN109562179A (zh) 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201780046065.1A Division CN109562179A (zh) 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途

Publications (1)

Publication Number Publication Date
CN121926911A true CN121926911A (zh) 2026-04-28

Family

ID=60202272

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202511855908.5A Pending CN121926911A (zh) 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途
CN201780046065.1A Pending CN109562179A (zh) 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201780046065.1A Pending CN109562179A (zh) 2016-08-05 2017-08-04 N,n-双-2-巯基乙基间苯二甲酰胺的新用途

Country Status (30)

Country Link
US (2) US20190240173A1 (https=)
EP (2) EP4029497A1 (https=)
JP (1) JP6926192B2 (https=)
KR (1) KR102538388B1 (https=)
CN (2) CN121926911A (https=)
AU (1) AU2017305661B2 (https=)
BR (1) BR112019002130A2 (https=)
CL (1) CL2019000229A1 (https=)
CY (1) CY1125039T1 (https=)
DK (1) DK3493849T3 (https=)
EA (1) EA201990443A1 (https=)
ES (1) ES2907838T3 (https=)
HR (1) HRP20220252T1 (https=)
HU (1) HUE057782T2 (https=)
IL (1) IL264538B2 (https=)
LT (1) LT3493849T (https=)
MA (1) MA45855B1 (https=)
MD (1) MD3493849T2 (https=)
MX (1) MX387853B (https=)
MY (1) MY199733A (https=)
PH (1) PH12019500237A1 (https=)
PL (1) PL3493849T3 (https=)
PT (1) PT3493849T (https=)
RS (1) RS62924B1 (https=)
SG (1) SG11201900565RA (https=)
SI (1) SI3493849T1 (https=)
SM (1) SMT202200109T1 (https=)
UA (1) UA125394C2 (https=)
WO (1) WO2018025049A1 (https=)
ZA (1) ZA201900594B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use
WO2026037909A1 (en) * 2024-08-16 2026-02-19 Emeramed Limited N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
US20120122787A1 (en) * 2009-07-10 2012-05-17 Rong Li Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
CA2775397A1 (en) 2009-09-28 2011-03-31 University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Also Published As

Publication number Publication date
SG11201900565RA (en) 2019-02-27
US20250325503A1 (en) 2025-10-23
PH12019500237A1 (en) 2019-10-28
JP6926192B2 (ja) 2021-08-25
RS62924B1 (sr) 2022-03-31
UA125394C2 (uk) 2022-03-02
ZA201900594B (en) 2019-08-28
SI3493849T1 (sl) 2022-04-29
CN109562179A (zh) 2019-04-02
MY199733A (en) 2023-11-21
BR112019002130A2 (pt) 2019-05-14
EP3493849A1 (en) 2019-06-12
LT3493849T (lt) 2022-03-10
MD3493849T2 (ro) 2022-04-30
DK3493849T3 (en) 2022-03-07
IL264538A (https=) 2019-03-31
MX387853B (es) 2025-03-19
IL264538B2 (en) 2023-02-01
ES2907838T3 (es) 2022-04-26
NZ750271A (en) 2025-07-25
CL2019000229A1 (es) 2019-04-26
SMT202200109T1 (it) 2022-05-12
KR20190035724A (ko) 2019-04-03
US20190240173A1 (en) 2019-08-08
MA45855B1 (fr) 2022-02-28
IL264538B (en) 2022-10-01
KR102538388B1 (ko) 2023-05-30
EP3493849B1 (en) 2021-12-01
EA201990443A1 (ru) 2019-07-31
PT3493849T (pt) 2022-02-23
AU2017305661B2 (en) 2023-05-18
MA45855A (fr) 2021-03-17
EP4029497A1 (en) 2022-07-20
AU2017305661A1 (en) 2019-02-14
PL3493849T3 (pl) 2022-03-28
HUE057782T2 (hu) 2022-06-28
WO2018025049A1 (en) 2018-02-08
CY1125039T1 (el) 2023-03-24
HRP20220252T1 (hr) 2022-04-29
MX2019000978A (es) 2019-06-10
CA3032858A1 (en) 2018-02-08
JP2019524782A (ja) 2019-09-05

Similar Documents

Publication Publication Date Title
JP6353577B2 (ja) 組み合わせ組成物
US20250325503A1 (en) New use of n,n-bis-2-mercaptoethyl isophthalamide
BRPI0707277B1 (pt) Composição, uso da mesma,e , formulação famacêutica
KR20010015890A (ko) 신경변성질환 치료약
WO2004058243A1 (ja) 肝癌発生・進展抑制剤
JP2024019691A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
ES2763437T3 (es) Composición para el tratamiento de la esterilidad
WO1999003466A1 (fr) Substance prophylactique ou therapeutique contre l'amnesie
JPWO2008123093A1 (ja) 鉄過剰症の予防または治療剤
TWI606826B (zh) 艾拉莫德或其鹽之用途
RU2250103C2 (ru) ПРИМЕНЕНИЕ (R)-АРИЛПРОПИОНОВЫХ КИСЛОТ ДЛЯ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ЛЮДЕЙ И ЖИВОТНЫХ, НА КОТОРЫЕ МОЖНО ОКАЗЫВАТЬ ТЕРАПЕВТИЧЕСКОЕ ВОЗДЕЙСТВИЕ ПУТЕМ ИНГИБИРОВАНИЯ АКТИВАЦИИ NF-κВ
US20080188537A1 (en) Method of treating bipolar depression with a benzamide derivative
ES2272383T3 (es) Uso de un agente que mejora la funcion astrocitica para el tratamiento de la enfermedad de parkison.
JP2024016228A (ja) アセトアミノフェン(apap)によって引き起こされる毒性を予防、低減または根絶するための方法および組成物
SG186388A1 (en) A combination composition comprising ibuprofen and paracetamol
CA3032858C (en) Use of n,n-bis-2-mercaptoethyl isophthalamide to prevent or treat paracetamol toxicity
JPH11209303A (ja) 腎不全治療薬及び腎不全患者用食品
US20060121034A1 (en) Treatment for alzheimer's disease and related conditions
HK40005150B (en) New use of n,n-bis-2-mercaptoethyl isophthalamide
JPWO2005089743A1 (ja) 腎性貧血治療剤
WO2026037909A1 (en) N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain
JPWO2004096230A1 (ja) 関節リウマチ治療剤
CN120513092A (zh) 磷酸镁物质、包含其的药物组合物及其用途
JPH078791B2 (ja) ジベンズ〔cd,f〕インド−ルの新規用途
JPH07291861A (ja) 炎症性腸疾患予防治療剤

Legal Events

Date Code Title Description
PB01 Publication